Intranasal pirodavir (R77,975) treatment of rhinovirus colds.

A randomized, double-blind, placebo-controlled trial assessed the therapeutic efficacy of intranasal pirodavir in naturally occurring rhinovirus colds. Adults with symptoms of < or = 2 days' duration were randomly assigned to intranasal sprays of pirodavir (2 mg per treatment) or placebo six times d...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hayden, F G, Hipskind, G J, Woerner, D H, Eisen, G F, Janssens, M, Janssen, P A, Andries, K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162529/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726484/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.290
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!